The implications of the OTC up-scheduling of codeine-containing medicines for Australians

Less than 24 hours since low-dose OTC codeine-containing medicines have been restricted to prescription only (Schedule 4), pharmacy is already raising concerns over potential consumer backlash. Fairfax reports an estimated 153,000 Australians use low-dose codeine-containing medicines at rates indicative of dependence, which the government has also dubbed as alarmingly high. By enforcing the up-scheduling of low-dose…

Read More

New blood test detects Alzheimer’s disease years earlier

Dementia has now taken the place of cancer as the second leading cause of death in Australia after heart disease. A team of scientists in Australia and Japan have developed the world’s first accurate blood test for detecting Alzheimer’s disease, which can identify the presence of the disease up to 20 years before symptoms begin.…

Read More

‘Baby brain’ is a real phenomenon

We have all heard the old wives’ tale of women experiencing ‘baby brain’ during pregnancy. Symptoms are thought to include forgetting things, losing your train of thought or having trouble with planning. Recent research from Deakin University, published in the Medical Journal of Australia has looked at the scope of data across 20 studies, involving…

Read More

Pharmacists to support Australians living with chronic pain

Pharmacies Australia-wide will be charged with helping patients who take chronic pain medication consistently for three months or more, under the Pain MedsCheck trial that will run up until June 2020 as part of the remaining Sixth Community Pharmacy Agreement. The new $20 million program to be funded under the Sixth Community Pharmacy Agreement will…

Read More